Vincent Dumouilla

Vincent Dumouilla

Auto-generated profile, based on publicly available information

Vincent Dumouilla


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
JGJesus Alfredo Godinez-Leon
Jesus Alfredo Godinez-Leon
TSTahmida Shamsuddin
Tahmida Shamsuddin
MFMaria-Thereza Fontenele
Maria-Thereza Fontenele
VDVincent Dumouilla
Vincent Dumouilla
BBBaptiste Boit
Baptiste Boit
RGRuxandra Gref
Ruxandra Gref
Epichlorohydrin-crosslinked β-cyclodextrin polymers (pCDs) are versatile drug carriers that solubilize poorly water-soluble molecules and exhibit intrinsic biological activity. However, the broad dispersity and ill-defined architecture of conventionally synthesized pCDs have hindered structure–property correlations at the molecular level. Here, we report the synthesis of pCDs with well-defined molecular weights and low dispersities, fully characterized for composition, size, and supramolecular organization. All pCD fractions enabled substantially higher linezolid (LZD) solubilization than native βCD, with association constants independent of molecular weight. NMR spectroscopy revealed a tilted aromatic insertion geometry for LZD within the βCD cavity and identified additional drug interactions in inter-cavity microdomains unique to the polymer. An atomistic pCD model, constructed for the first time, was subjected to molecular docking and microsecond molecular dynamics simulations. LZD preferentially associated with inter-cavity regions rather than undergoing spontaneous cavity inclusion, with binding limited primarily by kinetic and steric constraints rather than geometric incompatibility. These findings establish that pCDs bind drugs through multiple complementary modes, and demonstrate experimentally grounded atomistic simulation as a powerful framework for rational design of carbohydrate-based drug delivery platforms.